|
Video: What is a Stock Split?
|
|
Procaps Group conducts its business through its subsidiary, Crynssen Pharma Group Limited (Procaps), an integrated international healthcare and pharmaceutical company that has capabilities in developing and manufacturing Softgel capsules and related dosage forms as evidenced by its development of various pharmaceutical products formulations. Co.'s operating segments including: NextGel, Procaps Colombia, Central America North ("CAN"), Central America South & North Andes ("CASAN") - manufacturing and distribution of prescription and over-the-counter pharmaceutical products; and diabetrics, diabetes solutions and chronic disease management tool. According to our Procaps Group SA stock split history records, Procaps Group SA has had 0 splits. | |
|
Procaps Group SA (PROC) has 0 splits in our Procaps Group SA stock split history database.
Looking at the Procaps Group SA stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Procaps Group SA shares, starting with a $10,000 purchase of PROC, presented on a split-history-adjusted basis factoring in the complete Procaps Group SA stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/10/2019 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$9.84 |
|
End price/share: |
$2.82 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-71.34% |
|
Average Annual Total Return: |
-24.74% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,865.63 |
|
Years: |
4.40 |
|
|
|
|
|